Akero Therapeutics, Inc. (AKRO)

Last Year

14-May-23 -- 13-May-24

Time Period:

$1.80M Net Amount

Buy:	$1.98M	$19.83
Sell:	($181.57K)	$20.15 - $20.76

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

11

0

4

+1

0

+2

1

+3

Two Year Chart

14-May-22 -- 13-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Dec-23 10:00 PM View:	08-Dec-23 Market Purchase $1.98M	Graham G. Walmsley Director		Akero Therapeutics, Inc. - AKRO	99% 402.17K to 802.17K	$1.98M 25%	0	$19.83	--	Show Txns Hide Txns

15-Mar-24 4:45 PM View:	13-Mar-24 Private Sale ($20.48K)	Yale Catriona Chief Development Officer		Akero Therapeutics, Inc. - AKRO	(4%) 80.57K to 77.69K	0	($12.39K) (1%)	--	$20.76	Show Txns Hide Txns

21-Jun-23 5:47 PM View:	16-Jun-23 Option Sale ($2.17M)	Henderson Jane Director		Akero Therapeutics, Inc. - AKRO	0% --	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:42 PM View:	13-Mar-24 Private Sale ($17.54K)	Rolph Timothy Chief Scientific Officer		Akero Therapeutics, Inc. - AKRO	(4%) 189.93K to 182.56K	0	($10.67K)	--	$20.76	Show Txns Hide Txns

02-May-24 9:07 PM View:	01-May-24 Market Sale (Planned) ($100.75K)	Young Jonathan Chief Operating Officer		Akero Therapeutics, Inc. - AKRO	30% 244.28K to 318.31K	0	($112.02K) (2%)	--	$20.15 - $20.76	Show Txns Hide Txns

15-Mar-24 4:44 PM View:	13-Mar-24 Private Sale ($20.51K)	White William Richard Chief Financial Officer		Akero Therapeutics, Inc. - AKRO	116% 22.98K to 49.63K	0	($12.68K) (3%)	--	$20.76	Show Txns Hide Txns

21-Jun-23 5:54 PM View:	16-Jun-23 Option Sale ($1.42M)	Heyman Tomas J. Director		Akero Therapeutics, Inc. - AKRO	0% --	0	0	--	--	Show Txns Hide Txns

12-Dec-23 4:35 PM View:	08-Dec-23 Grant 0	Lamy Patrick See Remarks		Akero Therapeutics, Inc. - AKRO	100% 0 to 18.57K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:43 PM View:	13-Mar-24 Private Sale ($55.78K)	Cheng Andrew President and CEO Director		Akero Therapeutics, Inc. - AKRO	44% 409.29K to 589.45K	0	($33.80K)	--	$20.76	Show Txns Hide Txns